Bosch Exhibits Vivalytic All-in-One Analyzer for PCR Rapid Tests at MEDICA 2021

By LabMedica International staff writers
Posted on 18 Nov 2021

Image: Vivalytic Analyzer (Photo courtesy of Bosch Healthcare Solutions GmbH)

Bosch Healthcare Solutions GmbH (Waiblingen, Germany) exhibited its universal platform for molecular diagnostics that allows users to analyze a wide variety of sample materials in a fully automated way in a short time at MEDICA 2021.

The Vivalytic Analyzer from Bosch that was on display at the event allows infectious diseases to be diagnosed more quickly and easily than is the case today with manual tests in hospitals, laboratories, and medical practices. The platform combines different analysis methods in one device and is open to providers of further tests. The platform unites a wide spectrum of tests with a varying number of clinically relevant parameters on one device. The Vivalytic Analyzer enables fully automated PCR testing in laboratory quality – fast and directly at the point of care. The Vivalytic system consists of just a compact analysis device and cartridges the size of a smartphone. This enables rapid PCR tests to be carried out directly on site.

The Vivalytic Analyzer unites a wide variety of innovative technologies in one compact device. With only a touch display, a slot for inserting the test cartridge, a button and a scanner, the Analyser is very intuitive to use. This minimalistic design makes the Vivalytic system very user-friendly: medical professionals require only minimal training to be able to safely operate the Analyzer. Different types of samples can be tested fully automated with the Vivalytic Analyzer. The innovative technology reduces the need for manual preparation. The analyzer takes over this task before the analysis and evaluation takes place.

Bosch has developed a new rapid test for its Vivalytic analysis device to detect the SARS-CoV-2 pathogen. The test provides a reliable result in 39 minutes and is currently the fastest polymerase chain reaction (PCR) test worldwide. Results for positive samples are even delivered in less than 30 minutes. As a multiplex test, it simultaneously checks patient samples for the SARS-CoV-2 virus and nine other respiratory diseases in under two and a half hours. Bosch’s new rapid test is predestined for decentralized use in mobile test centers at freeway service stations or in airports. People who take the test can obtain a reliable result while at the testing site. Available now in Europe, the CE-approved test helps avoid time in quarantine, relieve laboratories, and make travel and work safer again.

Related Links:
Bosch Healthcare Solutions GmbH